MedTrace Logo

An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization

NCT05377879 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2022-07-21

No results posted yet for this study

Summary

Aim: A Clinical trial to determine the effectiveness of using the proposed decision support tool (OPTIVF) for each patient's customized optimal drug dosage profile. This will be a two-arm (in the ratio 1:3) clinical trial involving more than 80 participants; one arm will undergo superovulation using dosages predicted by the decision support tool while the other arm has undergone current standard treatment. The investigators will compare the outcomes of the two groups of participants in terms of the numbers and percentage of mature follicles retrieved at the end of each cycle, total FSH and HMG dosages used, and the number of required testing days for that cycle. The participants considered will include all ages, with and without PCOS, and low, average, and high responders.

Conditions

  • IVF

Interventions

DEVICE

OPT-IVF dosage

Dosage predicted for each patient by the decision support tool OPTIVF

Sponsors & Collaborators

  • Akansha Hospital and Research Institute, India

    collaborator UNKNOWN

  • Stochastic Research Technologies LLC

    lead INDUSTRY

Principal Investigators

  • Urmila Diwekar, Ph.D. · Stochastic Research Technologies/University of Illinois at Chicago

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-10
Primary Completion
2022-06-30
Completion
2022-07-01

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05377879 on ClinicalTrials.gov